GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Gross Profit

Neurotech International (ASX:NTI) Gross Profit : A$0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Gross Profit?

Neurotech International's gross profit for the six months ended in Dec. 2023 was A$-0.00 Mil. Neurotech International's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Neurotech International's gross profit for the six months ended in Dec. 2023 was A$-0.00 Mil. Neurotech International's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Neurotech International's Gross Margin % for the quarter that ended in Dec. 2023 was -50.00%.

Neurotech International had a gross margin of -50.00% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 7 years, the highest Gross Margin % of Neurotech International was 110.19%. The lowest was -200.00%. And the median was 9.81%.


Neurotech International Gross Profit Historical Data

The historical data trend for Neurotech International's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Gross Profit Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial -0.25 0.03 0.23 - 0.01

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.04 - 0.01 -

Competitive Comparison of Neurotech International's Gross Profit

For the Medical Devices subindustry, Neurotech International's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's Gross Profit distribution charts can be found below:

* The bar in red indicates where Neurotech International's Gross Profit falls into.



Neurotech International Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Neurotech International's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=0.006 - 0
=0.01

Neurotech International's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.002 - 0.003
=-0.00

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.01 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Neurotech International's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=-0.00 / 0.002
=-50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Neurotech International  (ASX:NTI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Neurotech International had a gross margin of -50.00% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Neurotech International Gross Profit Related Terms

Thank you for viewing the detailed overview of Neurotech International's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013